Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram versus desipramine switching strategies in treatment-resistant depression
ACTRN12610000564055Phase 4Completed
- Sponsor
- Group for the Study of Resistant Depression
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of citalopram and desipramine in treatment-resistant depression (TRD) (4 arms), sponsored by Group for the Study of Resistant Depression. Primary endpoint: Response. Started Jan 2000; status: completed.
02
Drugs
citalopramdesipramine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on ACTRN12610000564055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000564055.